(TP53), widely known as the “guardian of the genome,” is one of the most frequently altered genes in human cancer. While its canonical tumor-suppressive ...
Cate Hargett from Greenwood, MS urgently needs a bone marrow transplant due to a TP53 mutation, and donor drives are being ...
Rezatapopt is a first-in-class oral therapy designed to target the TP53 Y220C mutation. This mutation affects the p53 protein ...
Dysphagia in cancers of the lip, oral cavity, and pharynx patients: Impact on cachexia, hospitalization, and racial disparities on outcomes. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
Some children have already died and only a minority who inherit the mutation will escape cancer, a new report stated on Wednesday, Dec. 10 Becca Longmire is a digital news writer-reporter at PEOPLE.
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial We analyzed a cohort ...
Stocktwits on MSN
SLS stock slips after-hours as cancer pipeline silence frustrates retail — China licensing fight now in spotlight
Anticipated updates on the company’s leukemia drug SLS009 did not land, dampening near-term catalyst momentum. ・Earlier studies showed SLS009 triggered leukemia cell death and remained active in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results